Aflac(NYSE) AFL

Aflac Incorporated helps people pay for unexpected medical costs. It gives cash directly to customers to help with bills. The company serves policyholders in Japan and the United States.

Supplemental Protection for Everyone

• Aflac Japan: Provides cancer insurance, medical coverage, and savings-oriented products; represents the principal contributor to consolidated earnings.
• Aflac U.S.: Furnishes policies for accidents, short-term disability, and critical illnesses to American consumers and workers.
• Life Insurance: Offers term and whole life options including savings plans like the WAYS and child endowment products.
• Health Services: Delivers dental and vision plans via a dedicated platform to round out supplemental health benefits.

Recent Growth and Expansions

• Launched the Miraito cancer insurance product in March 2025 to update its core Japanese offerings.
• Introduced Anshin Palette, a new medical insurance product for the Japanese market, in December 2025.
• Established an external reinsurance transaction in the first quarter of 2026 to manage risk.
• Refreshed the Tsumitasu savings-type life insurance product to increase its market appeal.

Operational Scale and Distribution

Aflac maintains a deep presence in Japan through approximately 6,200 sales agencies and agreements with 356 banks. The company supports over 14 million cancer policies in the Japanese market alone.

Measuring Financial Performance

• Total revenues were $8.5 billion in the first six months of 2026, compared with $7.6 billion in the first six months of 2025.
• Net earnings reached $1.8 billion in the first six months of 2026, compared with $628 million in the first six months of 2025.
• Market capitalization reached $59.1 billion in the second quarter of 2026, up 4.4% year over year.
• Aflac repurchased $2.0 billion of its common shares during the six-month period ended June 30, 2026.
• Adjusted earnings, a measure that excludes items not related to normal operations, were $1.8 billion in the first six months of 2026.

Evolution and Stability

Aflac has evolved into a leader in supplemental health insurance by bridging gaps in traditional medical coverage. Its dual-market strategy in Japan and the United States provides a diversified base for operational stability.